Survivin - biology and potential as a therapeutic target in oncology - Test2 - elhamkhani - TriplyDB

Survivin - biology and potential as a therapeutic target in oncology

Survivin - biology and potential as a therapeutic target in oncology

http://www.wikidata.org/entity/Q26864567

about

Survivin: a unique target for tumor therapy FBW7-mediated ubiquitination and degradation of KLF5 Tumor cell survival pathways activated by photodynamic therapy: a molecular basis for pharmacological inhibition strategies Inducing death in tumor cells: roles of the inhibitor of apoptosis proteins.Circulating survivin levels in healthy and asthmatic pregnancy Adhesion molecule-mediated hippo pathway modulates hemangioendothelioma cell behavior Correlation of STAT1 with apoptosis and cell-cycle markers in esophageal squamous cell carcinoma Differential transcriptome profile of peripheral white cells to identify biomarkers involved in oxaliplatin induced neuropathy.Deptor enhances triple-negative breast cancer metastasis and chemoresistance through coupling to survivin expression Theranostic properties of a survivin-directed molecular beacon in human melanoma cells.Mitotic slippage and expression of survivin are linked to differential sensitivity of human cancer cell-lines to the Kinesin-5 inhibitor monastrol.Survivin expression and serum levels in pancreatic cancer.Prognostic significance of pretreatment VEGF, survivin, and Smac/DIABLO serum levels in patients with serous ovarian carcinoma.The SMAC mimetic BV6 sensitizes colorectal cancer cells to ionizing radiation by interfering with DNA repair processes and enhancing apoptosis.Protection effect of survivin protein overexpression on acute myocardial infarction in rats.Protein phosphatase PHLPP induces cell apoptosis and exerts anticancer activity by inhibiting Survivin phosphorylation and nuclear export in gallbladder cancer.Growth arrest DNA damage-inducible gene 45 gamma expression as a prognostic and predictive biomarker in hepatocellular carcinoma Prognostic implications of survivin and lung resistance protein in advanced non-small cell lung cancer treated with platinum-based chemotherapy.Association between survivin genetic polymorphisms and epidermal growth factor receptor mutation in non-small-cell lung cancer.Recent Advances on Small-Molecule Survivin Inhibitors.Expression characteristics of proteins of IGF-1R, p-Akt, and survivin in papillary thyroid carcinoma patients with type 2 diabetes mellitus.miRNA profiling in gastrointestinal stromal tumors: implication as diagnostic and prognostic markers.Fisetin, a dietary phytochemical, overcomes Erlotinib-resistance of lung adenocarcinoma cells through inhibition of MAPK and AKT pathways.AZD5582, an IAP antagonist that leads to apoptosis in head and neck squamous cell carcinoma cell lines and is eligible for combination with irradiation.Effects of 17-AAG on the cell cycle and apoptosis of H446 cells and the associated mechanisms.Breast cancer cells respond differently to docetaxel depending on their phenotype and on survivin upregulation.Guadecitabine (SGI-110) priming sensitizes hepatocellular carcinoma cells to oxaliplatin.Biological predictors of radiosensitivity in head and neck squamous cell carcinoma.Harnessing Solute Carrier Transporters for Precision Oncology.Evaluation of antitumor activity of survivin short interfering RNA delivered by lipid nanoparticles in colon cancer in vitro and in vivo.Survivin protects fused cancer cells from cell death.Curcumin Enhanced Busulfan-Induced Apoptosis through Downregulating the Expression of Survivin in Leukemia Stem-Like KG1a Cells Fisetin, a dietary bioflavonoid, reverses acquired Cisplatin-resistance of lung adenocarcinoma cells through MAPK/Survivin/Caspase pathway.BCL-W is a regulator of microtubule inhibitor-induced mitotic cell death.Drug conjugated nanoparticles activated by cancer cell specific mRNA.Silencing of survivin by YM155 induces apoptosis and growth arrest in hepatocellular carcinoma cells.Exploiting AR-Regulated Drug Transport to Induce Sensitivity to the Survivin Inhibitor YM155.Construction of a novel vector expressing Survivin-shRNA and fusion suicide gene yCDglyTK and its application in inhibiting proliferation and migration of colon cancer cells.Correlation between E-cadherin interactions, survivin expression, and apoptosis in MDCK and ts-Src MDCK cell culture models.Hypothyroidism reduces mammary tumor progression via Β-catenin-activated intrinsic apoptotic pathway in rats.

P2860

Q26747332-E7254AA4-96DF-4CE3-A66C-498B73CC7C54 Q27010419-86801845-F4BB-48A2-B255-7EEE17B3AD4F Q28085631-1A4AB680-EFC0-437B-B6A9-2E6480A9462A Q33632016-ED72792F-8A1A-4761-9E2B-B06DCDE2F24F Q34305838-F72FB288-6177-4707-A65E-684F1E5D8FD2 Q34592780-A6F633B1-C7F0-4CD2-A8D5-E051BA7BC25F Q34600682-2F7B4400-5087-4ED6-8144-5C2BD3D51CE7 Q34683946-320AD259-E100-4C7D-82F1-63D7653D0799 Q35214539-44ACCDDF-93AB-4794-BA93-31F81FF418F0 Q35515042-D8C1FE0D-8F12-4939-AFF6-99344BC67ACE Q35649837-E1B4D841-946D-4A34-90CF-9C850AAC48F3 Q35747223-123B93EF-6DA2-4F03-8FD1-D7C5D36336EC Q35929423-BE5C322A-C542-4DB8-94CD-76CC8C6EA0E2 Q36069954-2EA8BCA4-B5AF-4595-BF43-A8151C4720CA Q36182887-D9BB5490-B843-45A6-A136-DFA007AED292 Q36326349-4F6BEC00-7D3E-42E3-80C7-3C4F9C1600A6 Q36413954-4DBDE15D-E68A-43E3-A694-0C6E875E19C5 Q36503102-E9151431-ABD6-406C-ABCF-E6E4481FA841 Q37513440-11ACCAB7-E895-46C0-9547-9BFF833EB042 Q37689286-8D3D3B34-8C38-4C9A-814F-F43C1EE0316A Q37727258-F2188E35-CC3E-4BEC-A78E-B6FDC4AD13EF Q38602174-C7CAE7DA-8504-4EB5-A41C-200FBCA68D51 Q38728165-F7DA5E41-35CB-4558-B3DD-5E94DDCD112E Q38741247-76F9C7FE-B409-406D-9525-740B9D81AF98 Q38765634-95F806E9-0F67-40A7-8B83-9818DB82EBEB Q38833708-C40FC249-E544-4D84-AA56-E9174B4F31F9 Q38854734-97AF319F-5BBA-46FC-9740-0513995751C7 Q38896144-FA76D3F1-F695-4B65-8066-61B1DBCA8CF4 Q39204754-F484CD4B-6805-4994-BD8E-5E1FDE6B79E4 Q41145076-CD38C413-3BB9-4C57-9451-C4FC50983864 Q41616107-E40C49FA-213D-4D6A-BB58-D647A0AA579A Q41861089-2B2C0EC2-96C3-46D2-8E3B-263179F0A41E Q41876233-4E242221-9902-4E44-9425-D34FE6F4D8E9 Q41887304-5C326142-1E6D-4404-ACA4-460516A02CB8 Q42363695-13FA517A-DFC5-479D-96FD-977BE6C0E14A Q42457038-147E1BC5-FC6A-4346-8565-22E8EA8C20BF Q45058251-A7E00B8B-4DBC-40DB-8F0E-B93FEF3D5FE4 Q45875372-13B327B0-3025-4553-88E3-8594BC90E2ED Q46309170-9AD28FD5-4651-4E9D-AE56-1F35E3B59671 Q47861773-06EBB37C-57ED-487B-9442-9AA114CE7480

P2860

Survivin - biology and potential as a therapeutic target in oncology

http://www.wikidata.org/entity/Q26864567

description

2013 nî lūn-bûn

@nan

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Survivin - biology and potential as a therapeutic target in oncology

@ast

Survivin - biology and potential as a therapeutic target in oncology

@en

Survivin - biology and potential as a therapeutic target in oncology

@nl

type

label

Survivin - biology and potential as a therapeutic target in oncology

@ast

Survivin - biology and potential as a therapeutic target in oncology

@en

Survivin - biology and potential as a therapeutic target in oncology

@nl

prefLabel

Survivin - biology and potential as a therapeutic target in oncology

@ast

Survivin - biology and potential as a therapeutic target in oncology

@en

Survivin - biology and potential as a therapeutic target in oncology

@nl

P1433

Q26864567-A20E2860-5415-430A-84B9-A03F09C9858A

P1476

Q26864567-2B8676D4-E302-4478-B248-5360E2E4842A

P2093

Q26864567-16FF87ED-54E2-4FAD-B97F-7080E0FD3059

Q26864567-2E813475-23FC-4385-AB5C-8CE269D02117

Q26864567-42A04A78-1FC3-4E06-A385-931B842F9DEA

Q26864567-51D0B483-8CBC-4C71-BF06-B06DAFABD2BC

Q26864567-90326A12-7717-49C2-B772-B97141EAF2CD

Q26864567-98DA17A2-D8CB-4ECE-BE84-521B999D0715

Q26864567-BC469F79-48FD-4529-98DE-09ED1C063FE2

Q26864567-EB7C6AA6-ABE5-45DA-BA00-8CAA3B2B2F45

P2860

Q26864567-0198CE66-9570-4B67-A14E-2A4D8F3144C7

Q26864567-11824893-34D0-47A4-9BBD-7CFFCFB89403

Q26864567-12ADED8C-2507-4DB3-B9D4-CF51818A5572

Q26864567-17934AF8-7ABD-4527-B17D-464C91987693

Q26864567-20196432-AD67-4F5B-8657-4C3FD4883E2C

Q26864567-2369C63E-ECC0-42F1-9C3E-D7E9475B2B95

Q26864567-243927A7-8D74-4BEA-8186-B482E6FCB73E

Q26864567-25D78C1B-2313-4B15-AEA1-7D8CCE73AC19

Q26864567-293770CD-2BC9-4B5B-A360-A3F7EEE72B7E

Q26864567-2BD01FCD-7497-437E-8879-FF250E9B43F0

P304

Q26864567-165AEFEE-2670-443E-8CCE-52A28F86BB9C

P31

Q26864567-4999980E-AAC9-4844-8027-E3A9DBDBB031

P3181

Q26864567-877F5FA7-CCBA-4C2E-9C66-0FB5DE479F23

P356

Q26864567-16171DA4-4621-4EC7-AB6C-781ABFEDBFA0

P407

Q26864567-C572694A-5F17-47DB-B1A9-693448FC66D0

P478

Q26864567-5C5F0FFC-77AB-4665-8E3F-A440862E77D7

P50

Q26864567-E4B45402-C090-4627-A264-35EEE94D9382

P577

Q26864567-679111B4-28E9-4C6A-97E1-BD2198331D5F

P5875

Q26864567-4EA1E592-A8C0-46BA-A586-F0EA28B62F43

P698

Q26864567-3A2A4A2D-8EFD-4806-8460-6D67451F6958

P932

Q26864567-4B41886E-B927-49C0-B1B3-71E135A75A9D

P3181

P356

P1433

OncoTargets and Therapy

P1476

Survivin - biology and potential as a therapeutic target in oncology

@en

P2093

Chien-Chang Huang

http://www.w3.org/2001/XMLSchema#string

Fang-Ying Tsai

http://www.w3.org/2001/XMLSchema#string

Jane Ying-Chieh Lee

http://www.w3.org/2001/XMLSchema#string

Jang-Yang Chang

http://www.w3.org/2001/XMLSchema#string

Shang-Hung Chen

http://www.w3.org/2001/XMLSchema#string

Siao Muk Cheng

http://www.w3.org/2001/XMLSchema#string

Yi-Chun Huang

http://www.w3.org/2001/XMLSchema#string

Yung-Chieh Chang

http://www.w3.org/2001/XMLSchema#string

P2860

Control of apoptosis and mitotic spindle checkpoint by survivin

Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions

Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin

Hsp90: a specialized but essential protein-folding tool

Structure of a Survivin-Borealin-INCENP core complex reveals how chromosomal passengers travel together

Acetylation directs survivin nuclear localization to repress STAT3 oncogenic activity

Aurora-B phosphorylation in vitro identifies a residue of survivin that is essential for its localization and binding to inner centromere protein (INCENP) in vivo

The Survivin-Crm1 interaction is essential for chromosomal passenger complex localization and function

Interaction of Beclin 1 with survivin regulates sensitivity of human glioma cells to TRAIL-induced apoptosis

Endothelium derived nitric oxide synthase negatively regulates the PDGF-survivin pathway during flow-dependent vascular remodeling

P304

1453-1462

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

525350

http://www.w3.org/2001/XMLSchema#string

P356

10.2147/OTT.S33374

http://www.w3.org/2001/XMLSchema#string

P407

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

Chun Hei Antonio Cheung

P577

2013-10-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258350465

http://www.w3.org/2001/XMLSchema#string

P698

24204160

http://www.w3.org/2001/XMLSchema#string

P932

3804542

http://www.w3.org/2001/XMLSchema#string